Abstract
The current study aimed to improve the processability and oral bioavailability of itraconazole (ITZ) via spherical agglomeration. ITZ-spherical agglomerates (ITZ-SA) and ITZ-poloxamer 407-spherical agglomerates (ITZ-PLX-SA) were optimized using Box-Behnken design. Here, the drug release was affected by polymer concentration and stirring speed, whereas particle size was altered by stirring speed, polymer concentration, and amount of bridging liquid. Heckel and Kawakita studies showed a reduction in mean yield pressure and remarkably lowered 1/b value than ITZ, indicating better compactibility and flowability of ITZ-PLX-SA. Physicochemical interactions were not observed during the process, as indicated by ATR-FTIR, DSC, and XRPD. The significant improvement in % drug release of ITZ-PLX-SA was attributed to better wettability and the presence of polymer than ITZ-SA and ITZ. The pharmacokinetic study in rats indicated fivefold enhanced Cmax and twofold improved AUC for ITZ-PLX-SA than plain drug. Thus, spherical agglomeration could improve overall processability and pharmacokinetic profile of ITZ.
Graphical Abstract
Similar content being viewed by others
Data Availability
Data will be made available on request.
References
Wening K, Breitkreutz J. Oral drug delivery in personalized medicine: unmet needs and novel approaches. Int J Pharm. 2011;404:1–9.
Savjani KT, Gajjar AK, Savjani JK. Drug solubility: importance and enhancement techniques. ISRN Pharm. 2012;2012:1–10.
Khadka P, Ro J, Kim H, Kim I, Kim JT, Kim H, et al. Pharmaceutical particle technologies: an approach to improve drug solubility, dissolution and bioavailability. Asian J Pharm Sci. 2014;9:304–16.
Sowa M, Klapwijk AR, Ostendorf M, Beckmann W. Particle engineering of an active pharmaceutical ingredient for improved micromeritic properties. Chem Eng Technol. 2017;40:1282–92.
Kawashima Y, Imai M, Takeuchi H, Yamamoto H, Kamiya K, Hino T. Improved flowability and compactibility of spherically agglomerated crystals of ascorbic acid for direct tableting designed by spherical crystallization process. Powder Technol. 2003;130:283–9.
Chatterjee A, Gupta M, Srivastava B. Spherical crystallization: a technique use to reform solubility and flow property of active pharmaceutical ingredients. Int J Pharm Investig. 2017;7:4–9.
Chen H, Aburub A, Sun CC. Direct compression tablet containing 99% active ingredient—a tale of spherical crystallization. J Pharm Sci. 2019;108:1396–400.
Maghsoodi M, Nokhodchi A. Agglomeration of celecoxib by quasi emulsion solvent diffusion method: effect of stabilizer. Adv Pharm Bull. 2016;6:607–16.
Kedia K, Wairkar S. Improved micromeritics, packing properties and compressibility of high dose drug, cycloserine, by spherical crystallization. Powder Technol. 2018;344:665–72.
Nitsure A, Patel D, Wairkar S. Improved processability of ethambutol hydrochloride by spherical agglomeration. Pharm Dev Technol. 2020;25:376–84.
Chen H, Paul S, Xu H, Wang K, Mahanthappa MK, Sun CC. Reduction of punch-sticking propensity of celecoxib by spherical crystallization via polymer assisted quasi-emulsion solvent diffusion. Mol Pharm. 2020;17:1387–96.
Pitt K, Peña R, Tew JD, Pal K, Smith R, Nagy ZK, et al. Particle design via spherical agglomeration: a critical review of controlling parameters, rate processes and modelling. Powder Technol. 2018;326:327–43.
Fadke J, Desai J, Thakkar H. Formulation development of spherical crystal agglomerates of itraconazole for preparation of directly compressible tablets with enhanced bioavailability. AAPS PharmSciTech. 2015;16:1434–44.
Prentice AG, Glasmacher A. Making sense of itraconazole pharmacokinetics. J Antimicrob Chemother. 2005;56:17–22.
Parikh T, Sandhu HK, Talele TT, Serajuddin ATM. Characterization of solid dispersion of itraconazole prepared by solubilization in concentrated aqueous solutions of weak organic acids and drying. Pharm Res. 2016;33:1456–71.
Gummadi S, Varanasi S. UV spectrophotometric method development and validation for determination of an antifungal agent in bulk and capsules. Samson Isr /J Glob Trends Pharm Sci. 2019;1:11–7.
Kawakita K, Tsutsumi Y. A comparison of equations for powder compression. Bull Chem Soc Jpn. 1966;39:1364–8.
Jadhav N, Pawar A, Paradkar A. Design and evaluation of deformable talc agglomerates prepared by crystallo-co-agglomeration technique for generating heterogeneous matrix. AAPS PharmSciTech. 2007;8:E61–7.
Chavda V, Maheshwari R. Tailoring of ketoprofen particle morphology via novel crystallocoagglomeration technique to obtain a directly compressible material. Asian J Pharm. 2008;2:61.
Maghsoodi M, Taghizadeh O, Martin GP, Nokhodchi A. Particle design of naproxen-disintegrant agglomerates for direct compression by a crystallo-co-agglomeration technique. Int J Pharm. 2008;351:45–54.
Chow AHL, Leung MWM. A study of the mechanisms of wet spherical agglomeration of pharmaceutical powders. Drug Dev Ind Pharm. 1996;22:357–71.
Teychené S, Sicre N, Biscans B. Is spherical crystallization without additives possible? Chem Eng Res Des. 2010;88:1631–8.
Kawashima Y, Okumura M, Takenaka H. The effects of temperature on the spherical crystallization of salicylic acid. Powder Technol. 1984;39:41–7.
Maghsoodi M, Derakhshandeh K, Yari Z. On the mechanism of agglomeration in suspension. Adv Pharm Bull. 2012;2:25–30.
Chen K, Hou B, Wu H, Huang X, Li F, Xiao Y, et al. Hollow and solid spherical azithromycin particles prepared by different spherical crystallization technologies for direct tableting. Processes. 2019;7:276.
Yadav AV, Yadav VB. Preparation and evaluation of polymeric carbamazepin spherical crystals by emulsion solvent diffusion technique. Asian J Pharm. 2009;3:18–25.
Worku ZA, Kumar D, Gomes JV, He Y, Glennon B, Ramisetty KA, et al. Modelling and understanding powder flow properties and compactability of selected active pharmaceutical ingredients, excipients and physical mixtures from critical material properties. Int J Pharm. 2017;531:191–204.
Usha AN, Mutalik S, Reddy MS, Ranjith AK, Kushtagi P, Udupa N. Preparation and in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates. Eur J Pharm Biopharm. 2008;70:674–83.
Acknowledgements
The authors are thankful to Metrochem API Pvt Ltd, Hyderabad, India, for providing a gift sample of itraconazole.
Author information
Authors and Affiliations
Contributions
Hiral Kapalatiya: data collection, investigation, manuscript writing; Dhrumi Patel: data collection, investigation, data analysis, manuscript writing; Alok D. Singh: data collection, manuscript writing; Sarika Wairkar: conceptualization, methodology designing, supervision, manuscript review. and approval.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kapalatiya, H., Patel, D., Singh, A.D. et al. Processability and Oral Bioavailability Improvement of Itraconazole by Particle Engineering Technique. AAPS PharmSciTech 24, 27 (2023). https://doi.org/10.1208/s12249-022-02486-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1208/s12249-022-02486-4